Publications by authors named "Timothy Dudek"

Claim this Profile
E
Expression of SARS coronavirus 1 spike protein from a herpesviral vector induces innate immune signaling and neutralizing antibody responses.
Evelyn A Kurt-Jones, Timothy E Dudek, Daisuke Watanabe, Leisa Mandell, Jenny Che

Virology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia.
Daniel T Claiborne, Timothy E Dudek, Colby R Maldini, Karen A Power, Musie Ghebremichael

J Virol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection.
Stanley Adoro, Juan R Cubillos-Ruiz, Xi Chen, Maud Deruaz, Vladimir D Vrbanac, Timothy E Dudek

Nat Commun· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads.
Edward Seung, Timothy E Dudek, Todd M Allen, Gordon J Freeman, Andrew D Luster

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection.
Kerry J Lavender, Wendy W Pang, Ronald J Messer, Amanda K Duley, Brent Race, Timothy Dudek

Blood· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-specific CD8⁺ T-cell immunity in humanized bone marrow-liver-thymus mice.
Timothy E Dudek, Todd M Allen

J Infect Dis· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid evolution of HIV-1 to functional CD8⁺ T cell responses in humanized BLT mice.
Timothy E Dudek, Daniel C No, Edward Seung, Vladimir D Vrbanac, Lena Fadda

Sci Transl Med· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for differences in immunologic and pathogenesis properties of herpes simplex virus 2 strains from the United States and South Africa.
Timothy E Dudek, Ernesto Torres-Lopez, Clyde Crumpacker, David M Knipe

J Infect Dis· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein.
Natalia J Reszka, Timothy Dudek, David M Knipe

Vaccine· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic engineering of a modified herpes simplex virus 1 vaccine vector.
Xueqiao Liu, Eeva Broberg, Daisuke Watanabe, Timothy Dudek, Neal Deluca

Vaccine· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs.
Yo Hoshino, Lesley Pesnicak, Kennichi C Dowdell, Juan Lacayo, Timothy Dudek

Vaccine· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of the U(L)41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes.
Timothy Dudek, Lydia C Mathews, David M Knipe

Virology· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice.
Akram A Da'Dara, Norman Lautsch, Timothy Dudek, Vladimir Novitsky, Tun-Hou Lee

Vaccine· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis